Silvercrest Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.3M Sell
717,903
-61,845
-8% -$5.52M 0.49% 49
2026
Q1
$56M Sell
779,748
-100,438
-11% -$7.74M 0.4% 64
2025
Q4
$69.9M Sell
880,186
-41,849
-5% -$3.3M 0.48% 56
2025
Q3
$69.5M Sell
922,035
-52,052
-5% -$3.57M 0.46% 61
2025
Q2
$67.2M Sell
974,087
-34,151
-3% -$2.24M 0.45% 63
2025
Q1
$68.3M Buy
1,008,238
+94,247
+10% +$5.64M 0.49% 58
2024
Q4
$41M Sell
913,991
-305,699
-25% -$17.1M 0.27% 113
2024
Q3
$76.7M Sell
1,219,690
-59,766
-5% -$3.49M 0.52% 59
2024
Q2
$75.6M Sell
1,279,456
-83,518
-6% -$5.22M 0.52% 56
2024
Q1
$109M Buy
1,362,974
+3,201
+0.2% +$245K 0.74% 27
2023
Q4
$107M Buy
1,359,773
+30,554
+2% +$2.17M 0.76% 25
2023
Q3
$92.8M Sell
1,329,219
-36,688
-3% -$2.6M 0.7% 33
2023
Q2
$94.4M Buy
1,365,907
+19,982
+1% +$1.42M 0.67% 36
2023
Q1
$100M Sell
1,345,925
-36,335
-3% -$3.05M 0.76% 34
2022
Q4
$129M Buy
1,382,260
+12,377
+0.9% +$1.19M 0.99% 15
2022
Q3
$131M Sell
1,369,883
-89,861
-6% -$8.89M 1.07% 8
2022
Q2
$135M Buy
1,459,744
+7,035
+0.5% +$687K 1.03% 10
2022
Q1
$147M Sell
1,452,709
-181,234
-11% -$19M 0.96% 14
2021
Q4
$169M Buy
1,633,943
+12,369
+0.8% +$1.14M 1.07% 10
2021
Q3
$138M Sell
1,621,574
-2,935
-0.2% -$246K 0.93% 11
2021
Q2
$136M Sell
1,624,509
-22,124
-1% -$1.81M 0.89% 13
2021
Q1
$124M Buy
1,646,633
+41,669
+3% +$3.04M 0.84% 15
2020
Q4
$110M Buy
1,604,964
+5,385
+0.3% +$350K 0.8% 21
2020
Q3
$93.4M Sell
1,599,579
-6,205
-0.4% -$386K 0.8% 24
2020
Q2
$104M Sell
1,605,784
-7,064
-0.4% -$445K 0.93% 15
2020
Q1
$95.7M Sell
1,612,848
-9,803
-0.6% -$654K 1.03% 10
2019
Q4
$121M Buy
1,622,651
+16,506
+1% +$1.16M 0.94% 12
2019
Q3
$101M Buy
1,606,145
+228,964
+17% +$13.6M 0.84% 20
2019
Q2
$75M Buy
1,377,181
+217,967
+19% +$11.7M 0.7% 49
2019
Q1
$62.5M Buy
1,159,214
+447,178
+63% +$27.6M 0.61% 61
2018
Q4
$46.7M Buy
712,036
+73,056
+11% +$5.45M 0.51% 74
2018
Q3
$50.3M Buy
638,980
+109,102
+21% +$7.8M 0.46% 90
2018
Q2
$34.1M Sell
529,878
-5,434
-1% -$358K 0.32% 114
2018
Q1
$33.3M Sell
535,312
-841
-0.2% -$60.3K 0.32% 113
2017
Q4
$38.9M Sell
536,153
-20,742
-4% -$1.51M 0.36% 112
2017
Q3
$45.3M Sell
556,895
-12,005
-2% -$950K 0.45% 86
2017
Q2
$45.8M Sell
568,900
-9,211
-2% -$727K 0.49% 79
2017
Q1
$45.4M Sell
578,111
-76,903
-12% -$6.14M 0.49% 79
2016
Q4
$51.7M Sell
655,014
-89,499
-12% -$7.24M 0.58% 70
2016
Q3
$66.3M Sell
744,513
-3,495
-0.5% -$330K 0.8% 37
2016
Q2
$71.6M Buy
748,008
+3,867
+0.5% +$385K 0.91% 25
2016
Q1
$77.2M Sell
744,141
-39,047
-5% -$3.8M 1.06% 15
2015
Q4
$76.6M Buy
783,188
+29,120
+4% +$2.85M 1.06% 16
2015
Q3
$72.8M Sell
754,068
-30,505
-4% -$3.21M 1.11% 14
2015
Q2
$82.3M Sell
784,573
-10,116
-1% -$1.03M 1.1% 11
2015
Q1
$82M Sell
794,689
-4,141
-0.5% -$419K 1.16% 13
2014
Q4
$76.9M Sell
798,830
-10,324
-1% -$910K 1.12% 15
2014
Q3
$64.4M Buy
809,154
+148
+0% +$11.7K 0.99% 24
2014
Q2
$61M Sell
809,006
-29,735
-4% -$2.25M 0.91% 27
2014
Q1
$62.8M Sell
838,741
-48,903
-6% -$3.45M 1% 24
2013
Q4
$63.5M Sell
887,644
-5,461
-0.6% -$351K 1.05% 20
2013
Q3
$50.7M Sell
893,105
-624
-0.1% -$37.2K 0.97% 25
2013
Q2
$51.1M Buy
+893,729
New +$51.8M 1.08% 22

Other funds holding CVS

Silvercrest Asset Management's CVS Position: Q2 2026 in Review

Silvercrest Asset Management reduced its CVS Health (CVS) stake by 7.9% in Q2 2026, selling an estimated $5.52M and leaving 717,903 shares worth $74.3M. The position accounts for 0.49% of the portfolio, ranked #49.

Silvercrest Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $169M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Silvercrest Asset Management held 717,903 shares of CVS Health worth $74.3M as of Q2 2026.
  • Silvercrest Asset Management sold 61,845 CVS Health shares in Q2 2026, an estimated $5.52M.
  • CVS Health made up 0.49% of Silvercrest Asset Management's portfolio in Q2 2026, its #49 holding.
  • Silvercrest Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Silvercrest Asset Management's CVS Health position peaked at $169M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.